Trial intelligence / Profile preview

Comparison of Melatonin, Caffeine, and Dextromethorphan for Facilitating Anesthesia and Reducing Pain After Lumbar Disc Surgery

IRCT20191104045328N41Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of melatonin, caffeine and dextromethorphan in postoperative pain (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Facilitation of anesthesia and Postoperative pain reduction. Started Sep 2025; status: completed.

02

Drugs

melatonincaffeinedextromethorphan
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20191104045328N41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191104045328N41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call